Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific epstein-barr virus antigen-induced lymphocyte response
- 15 April 1982
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 29 (4), 407-412
- https://doi.org/10.1002/ijc.2910290408
Abstract
A unique association of Epstein‐Barr virus (EBV) with the undifferentiated nasopharyngeal carcinoma (NPC) is a well acknowledged phenomenon. We report here the detection of a factor present in the sera of NPC patients which inhibits the blastogenic response of lymphocytes from EBV seropositive individuals to EB virions or soluble antigens. This lymphocyte‐stimulation inhibitor (LSI) was found to be associated with the IgA fraction of the serum immunoglobulins. No inhibitory activity was detected in the sera and their immunoglobulin fractions from healthy (both EBV‐seropositive and seronegative) individuals and patients with other carcinomas of the head and neck region. Interestingly, the IgA‐LSI was absent in the sera of NPC patients who were successfully treated and remained in remission, while it was readily detectable in the sera of NPC patients in relapse. LSI‐positive IgA fractions did not inhibit mitogenic response of lymphocytes to phytohemagglutinin. Taken together, the data presented suggest that LSI is a specific inhibitor of the response of sensitized lymphocytes to EBV antigens and that it may indeed represent a marker of great clinical significance regarding undifferentiated nasopharyngeal carcinoma, particularly for its prognosis.This publication has 23 references indexed in Scilit:
- Abrogation of Cell-Mediated Immunity by a Serum Blocking Factor Isolated from Patients with Infectious MononucleosisThe Journal of Infectious Diseases, 1979
- Nasopharyngeal carcinoma: Significance of changes in epstein‐barr virus‐related antibody patterns following therapyInternational Journal of Cancer, 1977
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- THE EFFECT OF VIRAL INFECTIONS ON THE FUNCTION OF THE IMMUNE SYSTEMPublished by Elsevier ,1975
- Demonstration of epstein‐barr virus‐associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsiesInternational Journal of Cancer, 1974
- EB Viral Genomes in Epithelial Nasopharyngeal Carcinoma CellsNature New Biology, 1973
- In vitro stimulation of human lymphocytes by Epstein-Barr virusCellular Immunology, 1972
- Delayed Cutaneous Hypersensitivity Reactions to Autologous Extracts of Burkitt-Lymphoma CellsNew England Journal of Medicine, 1970
- Studies on cellular immunity and its serum‐mediated inhibition in moloney‐virus‐induced mouse sarcomasInternational Journal of Cancer, 1969
- Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.Proceedings of the National Academy of Sciences, 1968